Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)

Clinical trial NCT00116376 · COMPLETED

Trial details

NCT number: NCT00116376
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioblastoma Multiforme

Start date: 2004-01-01
Primary completion: 2005-11-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.